Orthopedic Surgery Doctors in Fort Hood, TX Accepting Medicare

6 Orthopedic Surgery doctors found. Showing 1 - 6

Nischal Nadig, DO Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 36065 Santa Fe Ave, Dept Of Orthopaedics, Fort Hood, TX 76544 Phone: 254-553-4111

Dr. Lydia Alicia Coffman, MD Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 36000 Darnall Loop, Dept Of Orthopedics Carl R Darnall Army Medical Center, Fort Hood, TX 76544 Phone: 254-288-8190

Kimberly Lynn Kesling, MD Orthopaedic Surgery - Orthopaedic Surgery of the Spine Medicare: Medicare Enrolled Practice Location: 36000 Darnall Loop, Carl R Darnall Army Medical Center, Fort Hood, TX 76544 Phone: 254-288-8185

Dr. Craig Kampfer, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 86065 Santa Fe Ave, Fort Hood, TX 76544 Phone: 254-288-8185

Dr. Peter Formby, MD Orthopaedic Surgery - Orthopaedic Surgery of the Spine Medicare: Medicare Enrolled Practice Location: Carl R. Darnall Army Medical Center, 36065 Sante Fe Ave, Fort Hood, TX 76544 Phone: 295-288-8000

Dr. Priscilla A West, M.D. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 36065 Santa Fe Ave, Carl R. Darnall Army Medical Center, Fort Hood, TX 76544 Phone: 254-288-8180

News Archive

Shuaiyi International New Resources Development closes private placement with accredited investors for $2.5 million

Shuaiyi International New Resources Development Inc. ("Shuaiyi" or the "Company"), a leading nutraceutical company focusing on the advanced technology related to the development of engineered "Cordyceps Militaris" in China, today announced the closing of a private placement with a group of accredited investors, pursuant to which the Company issued 1 million shares of the Company's common stock at a purchase price of $2.50 per share, for an aggregate purchase price of $2.5 million.

Scientists develop a new way to generate induced pluripotent stem cell lines from human fibroblasts

A team of New York Stem Cell Foundation (NYSCF) Research Institute scientists led by David Kahler, PhD, NYSCF Director of Laboratory Automation, have developed a new way to generate induced pluripotent stem (iPS) cell lines from human fibroblasts, acquired from both healthy and diseased donors.

Scripps scientist receives Novo Nordisk grant for research into diabetes

Andrew Butler, an associate professor in The Scripps Research Institute's Department of Metabolism and Aging, has been awarded one million dollars in funding over the next two years to further his research into a novel protein with the potential to improve the understanding and future treatment of diabetes.

Researchers screen Afro-Caribbean students to predict risk of heart disease

Researchers at the University of Hertfordshire are screening an Afro-Caribbean cohort of students this week to gauge their predisposition to heart disease in later life.

Read more Medical News

› Verified 3 days ago